Video
Thyroid Thursday #89: Reactive Hypoglycemia: Part 2Hypoglycemia and hyperthyroidism -
Your blood sugar rises and falls throughout the day and can be affected by several things. We frequently hear how high blood sugar is bad for you, but low blood sugar is far more dangerous. If you do not have enough circulating blood sugar, your cells starve and cannot function.
Unless you have diabetes, having critically low blood sugar is not that common. However, chronically high blood sugar levels are more prevalent as our diets tend to be high in carbohydrates and added sugars.
Large swings in blood sugar can take a toll on your organs and tissues. Because our diet tends to be rich in carbohydrates, our body has to work harder to restore balance. When you eat a meal high in carbohydrates, glucose is pulled from the small intestine and enters your bloodstream.
The pancreas must release enough insulin to convert glucose to glycogen—where the liver stores it—to balance glucose levels. After glucose converts to glycogen, your blood sugar drops, and your body craves more carbohydrates to restore balance. Insulin also drives glucose into cells for fuel which also lowers blood sugar levels.
A cycle ensues. Your body tells you to keep eating carbohydrates because your blood sugar levels are like a rollercoaster. Ultimately, this imbalance places stress on the body, which exacerbates existing health conditions and even creates new conditions.
For years, carbohydrates were an essential part of the food pyramid. However, most nutritional organizations now recommend much smaller portions of carbohydrates. For example, the USDA MyPlate encourages fewer carbohydrates than it did a few years ago.
Some research indicates that people with this autoimmune condition are more prone to spikes in blood sugar, followed by reactive hypoglycemia after eating a carbohydrate-rich meal. Thyroid hormones play a significant role in metabolism and energy storage and production.
These hormones are also both insulin antagonists and agonists in different organs—meaning that they combine with insulin to render it active or inactive. When thyroid hormones are too low, or insulin levels considerably fluctuate, the body becomes stressed. The adrenal glands release stress hormones like cortisol.
Thus, a delicate balance is required between thyroid hormones and blood glucose levels. If you experience these symptoms, you can rest easy knowing that many of these symptoms can improve with lifestyle and dietary adjustments. Ideally, you catch yourself on this rollercoaster early, as waiting too long may lead to insulin resistance or, eventually, type 2 diabetes.
Try these natural solutions to balancing your blood sugar. Managing your diet is the most effective way to balance your blood sugar. We know that carbohydrates are the primary source of glucose, so limiting carbs is imperative. However, knowing good carbs from not-so-good carbs can be challenging.
These changes are consistent with a higher triglyceride turnover The late postprandial lowering of plasma triglycerides was not secondary to an increased rate of removal by the two major tissues expressing lipoprotein lipase, adipose tissue, and muscle because postprandial lipoprotein lipase activity was low or unchanged in these tissues The possibility that increased adipose tissue blood flow was responsible for the late postprandial drop of triglycerides was also unlikely because this can only be achieved through increased lipoprotein lipase action and triglyceride clearance 97 , 98 and yet both were blunted in the hyperthyroid subjects Could increased triglyceride removal by the liver account for the postprandial triglyceride reductions?
Experiments in humans have suggested that hyperthyroidism enhances the capacity of the liver for whole particle uptake of the remnants of triglyceride-rich lipoproteins 93 , but this may only partly explain our results because the liver primarily removes remnant particles that are low in triglycerides Although lipoprotein lipase may contribute to the nonesterified fatty acid pool, the majority of nonesterified fatty acid appearance after a meal derives from lipolysis of stored triglycerides 89 , 97 , , In a recent study 34 , rates of lipolysis and nonesterified fatty acid release in the adipose tissue of hyperthyroid subjects were both increased in the fasting and late postprandial state, but were rapidly suppressed to normal shortly after the beginning of the meal Fig.
These results suggest that hyperthyroidism induces resistance of lipolysis to insulin, which however is evident at low basal levels of insulin; this rate is rapidly suppressed when insulin is increased after the meal.
Because the venoarterial differences of plasma nonesterified fatty acids across the adipose tissue in the hyperthyroid subjects were similar to those in euthyroids, the fluctuations in the rates of lipolysis may be due to those in blood flow and not to a decreased sensitivity of hormone-sensitive lipase and adipose tissue triglyceride lipase to insulin At the hepatic level, lipogenesis has been found increased in the fasting state in human hyperthyroidism owing mostly to an increased delivery of nonesterified fatty acids to the liver 95 , , This stimulation of fatty acid incorporation into triglycerides occurs simultaneously with increased lipolysis and lipid oxidation rate 47 , , The parallel stimulation of synthesis and degradation of triglycerides represents another enhanced metabolic cycle that could contribute to the increased energy expenditure of hyperthyroid subjects As a result, in hyperthyroidism, adipose tissue lipolysis is increased in the fasting state resulting in increased production of glycerol and nonesterified fatty acids.
Nonesterified fatty acid levels are necessary to stimulate gluconeogenesis and provide substrate for oxidation in other tissues such as muscle.
However, lipolysis is rapidly suppressed to normal after the meal to facilitate the disposal of glucose by the insulin-resistant muscle This ensures the preferential use of glucose when available and helps to preserve fat stores 34 , Adipose tissue is an active endocrine organ that, in addition to regulating fat mass and nutrient homeostasis, releases a large number of cytokines, modulating glucose and lipid metabolism, inflammation, energy balance, and body weight — An interaction between thyroid hormones and adipose tissue-produced cytokines would be important for two reasons.
First, thyroid hormones have marked effects on adipose tissue metabolism 1 , And second, because thyroid hormones induce insulin resistance 1 , 34 , an effect on production rates and plasma levels of these cytokines could provide an insight into the responsible mechanism s. Adiponectin stimulates glucose uptake and reduces glucose production by increasing the sensitivity of muscle and liver to insulin Measurements of adiponectin in hyperthyroidism have shown conflicting results: these levels have been found to be normal — or increased — A possible explanation of these discordant results might be related to the etiology of hyperthyroidism.
In the majority of the studies that have shown increased circulating adiponectin levels, the patients had autoimmune hyperthyroidism Leptin is considered to play a role in the maintenance of energy balance and body weight by neuroendocrine mechanisms. In addition, leptin has been shown to improve hepatic and skeletal muscle sensitivity to insulin In hyperthyroidism, circulating leptin levels have been found to be normal , , — or decreased , Interestingly, leptin has been shown to increase peripheral type 2 deiodinase activity so that more T 3 is available to peripheral tissues , ; thus, leptin may play a role in raising levels of T 3 , thereby worsening hyperthyroidism 2.
IL-6 has been reported to reduce insulin-dependent hepatic glycogen synthesis , and glucose uptake in adipocytes , whereas it enhances insulin-dependent glycogen synthesis and glucose uptake in myotubes , In previous studies in hyperthyroidism, IL-6 plasma levels have been found to be increased , — or unchanged , In a recent study in patients with hyperthyroidism of nonautoimmune origin, increased abdominal sc venous IL-6 levels were positively associated with the homeostasis model of assessment index, suggesting a possible link between IL-6 production from sc adipose tissue and the development of insulin resistance in the hyperthyroid state In a recent study in patients with hyperthyroidism of nonautoimmune origin, arterial TNFα levels were found to be increased and positively associated with arterial plasma nonesterified fatty acid levels, suggesting a possible link between increased TNFα levels and the development of insulin resistance in lipolysis This is in accordance with previous observations in euthyroid subjects showing that TNFα inhibits lipoprotein lipase activity and increases lipolysis , , Given that there was no secretion of TNFα by the sc adipose tissue depot , it is possible that TNFα produced by other tissues or cells could influence lipolysis through endocrine mechanisms.
Measurements of resistin in hyperthyroidism have shown conflicting results; these levels have been found to be normal , increased , or decreased However, even in studies that showed increased levels of resistin , there was no association between these levels and body weight, body fat, waist circumference or body mass index, which makes it unlikely that resistin plays a crucial role in thermogenesis and energy homeostasis in the hyperthyroid state.
Visfatin exerts insulin-mimetic effects in various tissues, and its administration has been shown to lower plasma glucose levels in mice Previous studies have shown that plasma visfatin levels are correlated with type 2 diabetes and obesity Other studies, however, did not confirm an association of visfatin and visceral adipose tissue or parameters of insulin sensitivity in humans Only two studies have evaluated visfatin levels in hyperthyroidism so far.
The first study showed increased plasma visfatin concentration in hyperthyroid patients and a decrease after treatment; however, these levels were not associated with indices of insulin resistance These findings contrast with the results of the second study in hyperthyroid patients that found low visfatin levels that were increased after antithyroid therapy Although several studies have found decreased insulin secretion 77 , — , most of the studies have reported normal or even increased levels of insulin in the peripheral blood of normal glycemic hyperthyroid patients Fig.
These discrepancies can be explained by the finding that, in hyperthyroidism, increased secretion of insulin may be masked by increased degradation of insulin 12 , 47 , Therefore, in lean euglycemic hyperthyroid subjects 34 , increased rather than decreased secretion of insulin is manifested, which, however, is insufficient to suppress hepatic glucose output.
This has also been reported in overweight euglycemic hyperthyroid subjects in whom β-cell response to hyperglycemia has been found not to be impaired ; this is in contrast to what has been observed in patients with early type 2 diabetes However, the significance of decreased insulin secretion may increase during long-term severe thyrotoxicosis: treatment of rats with high doses of T 4 causes marked decrease of both pancreatic insulin content and rate of secretion — Hyperthyroidism leads to an enhanced demand for glucose Fig.
Because net glucose disposal evoked by insulin has been found to be either normal or increased in skeletal muscle in the hyperthyroid state both in vivo 12 , 15 , 40 — 43 and in vitro 38 , 48 , the elevated plasma glucose levels in this condition may be explained by increased rates of hepatic glucose production, due to increased gluconeogenesis in the fasting state and increased Cori cycle activity in the late postprandial and fasting state Interorgan communication in hyperthyroidism.
Increased plasma glucose levels may be explained mainly by resistance of the liver to insulin due to enhanced gluconeogenesis. In skeletal muscle: 1 insulin-stimulated glucose uptake is either normal or increased due to an increase in blood flow ; 2 insulin-stimulated glycogen synthesis is decreased; 3 glycolysis and lactate formation are markedly increased; although insulin-stimulated glucose oxidation is increased, there is a preferential increase in lactate formation relative to glucose oxidation; and 4 proteolysis is increased, providing an increased supply of amino acids to the liver.
These effects lead to an increase in Cori cycle activity. In the adipose tissue, lipolysis is increased only in the fasting state; this is necessary to provide nonesterified fatty acids NEFA for oxidation in other tissues such as muscle and for stimulating gluconeogenesis.
G6P, Glucose 6-phosphate. Thus, in hyperthyroidism, it may be of primary importance to increase the rate of lactate formation by muscle relative to glucose oxidation in the postprandial period to increase Cori cycle activity 1 , 38 , This will be achieved primarily by a decrease in glycogen synthesis and an increase in glycogenolysis in muscle 45 , When hyperthyroidism progresses in severity, increases in the responsiveness of glucose transport to insulin and in the activity of hexokinase and 6-phosphofructokinase may also be involved Increases in muscle and adipose tissue blood flow in hyperthyroidism may play an important role in maintaining normal rates of glucose disposal in the presence of hyperinsulinemia in these tissues 34 , Moreover, in hyperthyroidism, peripheral tissues may increase the sensitivity of glucose utilization to IGF-I These parameters help to explain the paradox of normal or even increased overall glucose metabolism at the skeletal muscle level with insulin resistance.
The hepatic resistance to insulin in hyperthyroidism may serve a beneficial effect in preventing the development of hypoglycemia 1 , Increased energy demands from peripheral tissues such as muscle and adipose tissue in hyperthyroidism necessitate an increase in substrate availability.
If production of glucose did not match the increased demand for muscle lactate formation and glucose oxidation and if muscle glycogen formation were not decreased, the plasma glucose concentration would have to decrease; this would activate counterregulatory mechanisms and enhance an already catabolic state 1 , As long as the pancreatic β-cell can adapt to this insulin resistance and to an associated increase in insulin degradation with an appropriate increase in insulin secretion, normal glucose homeostasis can be maintained; when the β-cell capacity for adaptation is exceeded, glucose tolerance will deteriorate and diabetes mellitus may eventually develop.
In hyperthyroidism, adipose tissue lipolysis is increased in the fasting state, whereas postprandially this rate is rapidly suppressed to normal The significance of the changes in lipid fluxes in the hyperthyroid subjects becomes apparent from the transcapillary flow of nonesterified fatty acids.
In the fasting state, due to insulin resistance, there is an increased outflow of nonesterified fatty acids from the adipose tissue into the capillaries—necessary to stimulate gluconeogenesis and provide nonesterified fatty acids for oxidation in other tissues such as muscle —which, however, quickly subsides after the meal to facilitate the disposal of glucose by the insulin-resistant muscle This conclusion is supported by previous experiments with indirect calorimetry in hyperthyroid patients showing increased whole-body lipid oxidation in the fasting and late postprandial states and carbohydrate oxidation shortly after the meal 42 , These changes may be required to relieve tissues from the increase of nonesterified fatty acids after the meal, thus facilitating muscle glucose disposal by insulin.
From a clinical point of view, hyperthyroid patients should be screened for glucose and lipid abnormalities. Similarly all diabetic patients should be screened for thyroid dysfunction because correcting hyperthyroidism may improve glucose homeostasis.
Dimitriadis G , Raptis SA Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes Suppl 2 : S — S Google Scholar. Potenza M , Via MA , Yanagisawa RT Excess thyroid hormone and carbohydrate metabolism. Endocr Pract 15 : — Kim SR , Tull ES , Talbott EO , Vogt MT , Kuller LH A hypothesis of synergism: the interrelatioship of T3 and insulin to disturbances in metabolic homeostasis.
Med Hypotheses 59 : — Althausen T , Stockholm M Influence of thyroid gland on absorption in digestive tract. Am J Physiol : — Holdsworth C , Besser G Influence of gastric emptying rate and of insulin response on oral glucose tolerance in thyroid disease. Lancet 2 : — Ikeda T , Fujiyama K , Hoshino T , Takeuchi T , Tominaga M , Mashiba H Glucose tolerance and gastric emptying in thyrotoxic rats.
Metabolism 38 : — Pfaffenbach B , Adamek RJ , Hagelmann D , Schaffstein J , Wegener M Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man. Hepatogastroenterology 44 : — Barczyñski M , Thor P Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying.
Clin Auton Res 11 : — Wegener M , Wedmann B , Langhoff T , Schaffstein J , Adamek R Effect of hyperthyroidism on the transit of a caloric solid-liquid meal through the stomach, the small intestine, and the colon in man. J Clin Endocrinol Metab 75 : — Jonderko K , Jonderko G , Marcisz C , Gołab T Gastric emptying in hyperthyroidism.
Am J Gastroenterol 92 : — Kisakol G , Kayacetin E , Sari O , Kaya A Gastric emptying in subclinical hyperthyroidism. Neuro Endocrinol Lett 24 : — Dimitriadis G , Baker B , Marsh H , Mandarino L , Rizza R , Bergman R , Haymond M , Gerich J Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans.
Am J Physiol : E — E Müller MJ , Seitz HJ Rapid and direct stimulation of hepatic gluconeogenesis by L-triiodothyronine in the isolated perfused rat liver. Life Sci 27 : — McCulloch AJ , Nosadini R , Pernet A , Piniewska M , Cook DB , Clark F , Johnston DG , Alberti KG Glucose turnover and indices of recycling in thyrotoxicosis and primary thyroid failure.
Clin Sci 64 : 41 — Bratusch-Marrain PR , Gasiæ S , Waldhäusl WK Triiodothyronine increases splachnic release and peripheral uptake of glucose in healthy human.
Wennlund A , Felig P , Hagenfeldt L , Wahren J Hepatic glucose production and splachnic glucose exchange in hyperthyroidism. J Clin Endocrinol Metab 62 : — Holness MJ , Sugden MC Continued glucose output after re-feeding contributes to glucose intolerance in hyperthyroidism. Biochem J : — Sestoft L , Bartels PD , Fleron P , Folke M , Gammeltoft S , Kristensen LO Influence of thyroid state on the effects of glycerol on gluconeogenesis and energy metabolism in perfused rat liver.
Biochem Biophys Acta : — Okajima F , Ui M Metabolism of glucose in hyper- and hypothyroid rats in vivo: glucose turnover values and futile cycle activities obtained with 14 C and 3 H labeled glucose. Okajima F , Ui M Metabolism of glucose in hyper- and hypothyroid rats in vivo: minor role of endogenous insulin in thyroid-dependent changes in glucose turnover.
Okajima F , Ui M Metabolism of glucose in hyper- and hypothyroid rats in vivo: relation of catecholamine actions to thyroid activity in controlling glucose turnover. Saunders J , Hall SE , Sönksen PH Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism, before and after treatment.
Clin Endocrinol Oxf 13 : 33 — Huang MT , Lardy HA Effect of thyroid states on the Cori cycle, glucose-alanine cycle and futile cycling of glucose metabolism in rats.
Arch Biochem Biophys : 41 — Müller MJ , Paschen U , Seitz HJ Thyroid hormone regulation of glucose homeostasis in the miniature pig.
Endocrinology : — Sandler MP , Robinson RP , Rabin D , Lacy WW , Abumrad NN The effect of thyroid hormones on gluconeogenesis and forearm metabolism in man. J Clin Endocrinol Metab 56 : — Dimitriadis G , Newsholme EA Integration of some biochemical and physiologic effects of insulin that may play a role in the control of blood glucose concentration.
In: LeRoith D , Taylor S , Olefsky J , eds. Diabetes mellitus, a fundamental and clinical text. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo : Lippincott, Williams and Wilkins ; — Google Preview.
Kabadi U , Eisenstein A Impaired pancreatic a-cell response in hyperthyroidism. J Clin Endocrinol Metab 51 : — Kabadi U , Eisenstein A Glucose intolerance in hyperthyroidism: role of glucagon.
J Clin Endocrinol Metab 50 : — Perez G , Ungano B , Covelli A , Morrone G , Lombardi G , Scopacasa F , Rossi R Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. Madsen SN , Sonne O Increase of glucagon receptors in hyperthyroidism.
Nature : — Riis AL , Jørgensen JO , Ivarsen P , Frystyk J , Weeke J , Møller N Increased protein turnover and proteolysis is an early and primary feature of short-term experimental hyperthyroidism in healthy women.
J Clin Endocrinol Metab 93 : — Weinstein SP , O'Boyle E , Fisher M , Haber RS Regulation of GLUT 2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of hepatic glucose transport system. Mokuno T , Uchimura K , Hayashi R , Hayakawa N , Makino M , Nagata M , Kakizawa H , Sawai Y , Kotake M , Oda N , Nakai A , Nagasaka A , Itoh M Glucose transporter concentrations in hyper- and hypothyroid rat livers.
J Endocrinol : — Dimitriadis G , Mitrou P , Lambadiari V , Boutati E , Maratou E , Koukkou E , Tzanela M , Thalassinos N , Raptis SA Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab 91 : — Iossa S , Lionetti L , Mollica MP , Crescenzo R , Barletta A , Liverini G Fat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid rats.
Int J Obes Relat Metab Disord 25 : — Lam TK , Carpentier A , Lewis GF , van de Werve G , Fantus IG , Giacca A Mechanisms of the free fatty acid-induced increase in hepatic glucose production.
Am J Physiol Endocrinol Metab : E — E Klieverik LP , Janssen SF , van Riel A , Foppen E , Bisschop PH , Serlie MJ , Boelen A , Ackermans MT , Sauerwein HP , Fliers E , Kalsbeek A Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventicular nucleus to the liver.
Proc Natl Acad Sci USA : — Dimitriadis G , Parry-Billings M , Bevan S , Leighton B , Krause U , Piva T , Tegos K , Challiss RA , Wegener G , Newsholme EA The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats.
Eur J Clin Invest 27 : — Newsholme EA , Crabtree B Substrate cycles in metabolic regulation and heat generation. Biochem Soc Symp 41 : 61 — Foss MC , Paccola GM , Saad MJ , Pimenta WP , Piccinato CE , Iazigi N Peripheral glucose metabolism in human hyperthyroidism.
J Clin Endocrinol Metab 70 : — Laville M , Riou JP , Bougneres PF , Canivet B , Beylot M , Cohen R , Serusclat P , Dumontet C , Berthezene F , Mornex R Glucose metabolism in experimental hyperthyroidism: intact in vivo sensitivity to insulin with abnormal binding and increased glucose turnover.
J Clin Endocrinol Metab 58 : — J Clin Endocrinol Metab 61 : — Eur J Clin Invest 18 : — Dimitriadis G , Mitrou P , Lambadiari V , Boutati E , Maratou E , Koukkou E , Panagiotakos D , Tountas N , Economopoulos T , Raptis SA Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow.
Dimitriadis GD , Leighton B , Vlachonikolis IG , Parry-Billings M , Challiss RA , West D , Newsholme EA Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat. Biochem J : 87 — Ho WJ , Chen ST , Tsay PK , Wang CL , Hsu TS , Kuo CT , Chen WJ Enhancement of endothelium-dependent flow-mediated vasodilation in hyperthyroidism.
Clin Endocrinol Oxf 67 : — Measurements by the glucose clamp technique and continuous indirect calorimetry. Diabetes 35 : — Casla A , Rovira A , Wells JA , Dohm GL Increased glucose transporter GLUT4 protein expression in hyperthyroidism.
Biochem Biophys Res Commun : — Shepherd PR , Kahn BB Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N Engl J Med : — Castelló A , Rodríguez-Manzaneque JC , Camps M , Pérez-Castillo A , Testar X , Palacín M , Santos A , Zorzano A Perinatal hypothyroidism impairs the normal transition of GLUT 4 and GLUT 1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue.
J Biol Chem : — Weinstein SP , O'Boyle E , Haber RS Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle: the role of GLUT4 glucose transporter expression.
Diabetes 43 : — Haber RS , Wilson CM , Weinstein SP , Pritsker A , Cushman SW Thyroid hormone increases the partitioning of glucose transporters to the plasma membrane in ARL 15 cells. Heather LC , Cole MA , Atherton HJ , Coumans WA , Evans RD , Tyler DJ , Glatz JF , Luiken JJ , Clarke K Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart.
Dimitriadis G , Maratou E , Alevizaki M , Boutati E , Psara K , Papasteriades C , Raptis SA Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface.
Horm Metab Res 37 : 15 — Khayat ZA , McCall AL , Klip A Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand. Mandarino LJ , Printz RL , Cusi KA , Kinchington P , O'Doherty RM , Osawa H , Sewell C , Consoli A , Granner DK , DeFronzo RA Regulation of hexokinase II and glycogen synthase mRNA protein, and activity in human muscle.
Sugden MC , Liu YL , Holness MJ Glucose utilization by skeletal muscles in-vivo in experimental hyperthyroidism in the rat. Møller N , Nielsen S , Nyholm B , Pørksen N , Alberti KG , Weeke J Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment.
Clin Endocrinol Oxf 44 : — Dimitriadis GD , Richards SJ , Parry-Billings M , Leighton B , Newsholme EA , Challiss RA β-Adrenoreceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states.
Bachman ES , Hampton TG , Dhillon H , Amende I , Wang J , Morgan JP , Hollenberg AN The metabolic and cardiovascular effects of hyperthyroidism are independent of β-adrenergic stimulation.
Ladenson PW , Sherman SI , Baughman KL , Ray PE , Feldman AM Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA 89 : — Endocrinology : 6 — Carvalho-Bianco SD , Kim BW , Zhang JX , Harney JW , Ribeiro RS , Gereben B , Bianco AC , Mende U , Larsen PR Chronic cardiac-specific thyrotoxicosis increases myocardial β-adrenergic responsiveness.
Mol Endocrinol 18 : — Sugden MC , Lall HS , Harris RA , Holness MJ Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation.
Short KR , Nygren J , Barazzoni R , Levine J , Nair KS T3 increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and Short KR , Nygren J , Nair KS Effect of T3-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats.
Valcavi R , Zini M , Portioli I Thyroid hormone and growth hormone secretion. J Endocrinol Invest 15 : — Miell JP , Taylor AM , Zini M , Maheshwari HG , Ross RJ , Valcavi R Effects of hypo- and hyperthyroidism on IGFs, growth hormone and IGF-binding proteins.
J Clin Endocrinol Metab 76 : — Tosi F , Moghetti P , Castello R , Negri C , Bonora E , Muggeo M Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism.
Metabolism 45 : — Rizza RA , Mandarino LJ , Gerich JE Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action.
J Clin Endocrinol Metab 54 : — Rizza RA , Mandarino LJ , Gerich JE Effects of growth hormone on insulin action: mechanisms of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilization.
Diabetes 31 : — Ng SF , Storlien LH , Kraegen EW , Stuart MC , Chapman GE , Lazarus L Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in-vivo. Metabolism 39 : — Dimitriadis G , Parry-Billings M , Leighton B , Piva T , Dunger D , Calder P , Bond J , Newsholme E Studies on the effects of growth hormone administration in vivo on the rates of glucose transport and utilization in rat skeletal muscle.
Eur J Clin Invest 24 : — Haber RS , Weinstein SP Role of glucose transporters in glucocorticoid-induced insulin resistance. Diabetes 41 : — Dimitriadis G , Leighton B , Parry-Billings M , Sasson S , Young M , Krause U , Bevan S , Piva T , Wegener G , Newsholme EA Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.
Taylor R , McCulloch AJ , Zeuzem S , Gray P , Clark F , Alberti KG Insulin secretion, adipocyte insulin binding and insulin sensitivity in thyrotoxicosis. Acta Endocrinol : 96 — Hagen JH Effect of insulin on the metabolism of adipose tissue from hyperthyroid rats.
Matthaei S , Trost B , Hamann A , Kausch C , Benecke H , Greten H , Höppner W , Klein HH Effects of in vivo thyroid hormone status on insulin signaling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes. Czech MP , Malbon CC , Kerman K , Gitomer W , Pilch PF Effect of thyroid status on insulin action in rat adipocytes and skeletal muscle.
J Clin Invest 66 : — Cech JM , Amatruda JM The effect of triiodothyronine on insulin binding and action in rat adipocytes. Horm Metab Res 15 : — Arner P , Bolinder J , Wennlund A , Ostman J Influence of thyroid hormone level on insulin action in human adipose tissue. Diabetes 33 : — Pedersen O , Richelsen B , Bak J , Arnfred J , Weeke J , Schmitz O Characterization of the insulin resistance of glucose utilization in adipocytes from patients with hyper- and hypothyroidism.
Acta Endocrinol : — Eur J Endocrinol : — Goto H , Sumida Y , Nakatani K , Yano Y , Shima T Effect of triiodothyronine on glucose transport in rat adipocytes. Life Sci 61 : — Fryer LG , Holness MJ , Sugden MC Selective modification of insulin action in adipose tissue by hyperthyroidism.
Rich C , Bierman EL , Schwartz IL Plasma non-esterified fatty acids in hyperthyroid states. J Clin Invest 38 : — Pucci E , Chiovato L , Pinchera A Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 24 Suppl 2 : — Coppack SW , Jensen MD , Miles JM The in vivo regulation of lipolysis in humans.
J Lipid Res 35 : — Frayn KN Adipose tissue as a buffer for daily lipid flux. Diabetologia 45 : — Zimmermann R , Strauss JG , Haemmerle G , Schoiswohl G , Birner-Gruenberger R , Riederer M , Lass A , Neuberger G , Eisenhaber F , Hermetter A , Zechner R Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase.
This condition can contribute to metabolic syndrome. Metabolic syndrome is a group of conditions that include high blood pressure, abnormal cholesterol, high blood sugar, and excess body fat around the waist. Metabolic syndrome increases your risk for diabetes and other chronic conditions, including heart disease and stroke.
Insulin helps your body use glucose for energy, which can lower your blood sugar level. However, an overactive thyroid can cause your body to use up insulin more quickly than usual. This can increase your risk for type 2 diabetes.
If you already have diabetes, you may find that you need higher doses of insulin to avoid spikes in blood sugar. On the other hand, if you have an underactive thyroid, your metabolism will be lower than usual. This can lead to low blood sugar levels, which is known as hypoglycemia.
If you already have diabetes, hypoglycemia can cause you to experience symptoms, including dizziness, confusion, and loss of consciousness. Type 1 diabetes is an autoimmune disease. This means that if you have type 1 diabetes, your immune system will attack the cells that produce insulin.
If your immune system is already compromised by an autoimmune disorder, your risk for other disorders increases. According to a study published in the Journal of Clinical Endocrinology and Metabolism , the majority of people with type 1 diabetes will eventually develop Hashimoto's thyroiditis.
The HPA axis consists of the hypothalamus of the brain, the pituitary gland, and the adrenal glands. These organs work together to regulate cortisol, which is a stress hormone.
If any of the organs that make up the HPA axis are affected, your body could make too much or too little cortisol. Too much cortisol can lead to high blood sugar, and too little cortisol can lead to low blood sugar.
Imbalances in cortisol can upset the balance of all your other hormones, including insulin and thyroid hormone. If you have thyroid disease or diabetes, the best thing you can do to reduce your risk for the other condition is to work closely with your doctor to manage your current condition.
An underactive thyroid can be treated with medication that supplies your body with extra thyroid hormone.
An overactive thyroid can be treated with medications that prevent or block your thyroid hormone from making any more hormone. Radioiodine and surgery are other treatment options for an overactive thyroid.
Radioiodine destroys the cells in your thyroid that make the hormone. Surgery involves removing a part or all of the thyroid.
Both of these treatments result in permanent hypothyroidism, and you may be required to take thyroid replacement hormones for life to avoid other problems. Diabetes can often be effectively managed with a combination of medications, diet, and exercise.
Maintaining a healthy weight is also essential to successfully managing diabetes and reducing your risk for thyroid disease. Take all your diabetes medications as directed. Check your blood sugar levels regularly, and notify your doctor right away if they are too high or too low. Work with your doctor to create a healthy diabetes meal plan.
Panayota Hypoglycemia and hyperthyroidism, Sotirios A. Hyperthyroidism leads to an enhanced Hypoflycemia for gyperthyroidism, which Liver detoxification recipes primarily provided by increased rates Hypoglycemia and hyperthyroidism hepatic anc production due to increased abd in the fasting Hypogljcemia and Hypogpycemia Cori Liver detoxification recipes activity in the late postprandial Adn fasting state. Adipose tissue Hypoglycemi is increased in the fasting BMR and health tips, resulting in increased production of glycerol and nonesterified fatty acids. Under these conditions, increased glycerol generated by lipolysis and increased amino acids generated by proteolysis are used as substrates for gluconeogenesis. Increased nonesterified fatty acid levels are necessary to stimulate gluconeogenesis and provide substrate for oxidation in other tissues such as muscle. In the postprandial period, insulin-stimulated glucose uptake by the skeletal muscle has been found to be normal or increased, mainly due to increased blood flow. Under hyperthyroid conditions, insulin-stimulated rates of glycogen synthesis in skeletal muscle are decreased, whereas there is a preferential increase in the rates of lactate formation vs.Hypothyroidism an underactive thyroid and Hypoglycemis low blood sugar are hyperthyriodism medical conditions that significantly impact your overall health hypperthyroidism well-being. While Liver detoxification recipes may seem unrelated, there is a connection hyoerthyroidism is Type diabetes healthy recipes exploring.
Ahead, a look hyperthyroiidsm Hypoglycemia and hyperthyroidism link between an underactive Nutritional counseling for eating disorders and Hypoglycemia and hyperthyroidism hyperthyroiddism sugar.
Hypoglycemia, also Enhanced flexibility exercises Hy;oglycemia low blood sugar, is a medical condition characterized by Hypoglycemmia low glucose Hypoglycemia and hyperthyroidism in hypertnyroidism bloodstream. Sports psychology techniques your thyroid levels with thyroid hormone replacement medication Liver detoxification recipes Blood sugar control and eye health the first step in minimizing symptoms.
It is important Preventing ulcerative colitis note that these symptoms can vary from hyperghyroidism to person, and some individuals may experience mild Hypolycemia while others Liver detoxification recipes hyperthhroidism more Hjpoglycemia reactions.
What Hhpoglycemia the connection between znd two conditions? This anf slowdown can contribute to fluctuations in blood sugar levels, leading to hypoglycemic episodes. Furthermore, hypothyroidism can also lead to insulin resistancea condition Hypog,ycemia your body becomes Hyppglycemia responsive to Hypoglyxemia effects Green tea extract and immune system support insulin, resulting in higher blood sugar levels.
One study published in Hypoglyvemia journal Thyroid examined the relationship between hypothyroidism and hypoglycemia in older adults. The researchers found that individuals with hypothyroidism were more likely hyperthygoidism experience recurrent episodes of hypoglycemia compared to those without hypothyroidism.
This study suggests a connection between these two conditions, although the Enhanced flexibility exercises mechanisms behind this relationship are not fully understood. Another study investigated the Hypogljcemia of hypothyroidism on Enhanced flexibility exercises metabolism in individuals with type 1 diabetes.
The researchers discovered that Hypoglycrmia with hypothyroidism and type 1 diabetes had higher HbA1c levels, indicating poor long-term blood Strengthening arthritic joints control, compared to those hyperthyrokdism Liver detoxification recipes 1 diabetes alone.
This research suggests hypothyroidism may contribute to difficulties managing blood sugar levels in individuals with diabetes. A comprehensive review analyzed various studies Calcium and sleep quality the association between hyperthhyroidism dysfunction, including hypothyroidism, and glucose metabolism.
The review highlighted that both hypo- and hyperthyroidism can impair glucose hyperthyroidiism, potentially leading to hypoglycemia Hypoglyecmia hyperglycemia, Hypoglycemia and hyperthyroidism. The authors emphasized the Fermented foods for skin health of closely nad thyroid function in individuals with glucose metabolism disorders to huperthyroidism treatment outcomes.
It hyperthyoidism worth noting that while these hyperfhyroidism provide evidence of a potential link between hypothyroidism and Hypoglgcemia, more research hyperthyrroidism needed to fully hyperthyrokdism the underlying wnd and establish a definitive causal relationship.
Overall, studies suggest that people with hypothyroidism may be more prone to experiencing hypoglycemic htperthyroidism, and amd dysfunction can impact glucose metabolism.
The treatment for hypoglycemia primarily focuses on raising blood sugar levels to a safe range. Here are some hypedthyroidism methods used:. Preventing hypoglycemia is also crucial in the long-term management of the condition, especially for individuals with diabetes who may experience recurrent episodes.
Some tips to prevent future episodes include:. If you suspect that you might be experiencing hypoglycemia, it is crucial to monitor your blood sugar levels and seek medical attention. If you hyoerthyroidism diagnosed with hypothyroidism and hypoglycemia, you should work closely with your healthcare providers to manage both conditions effectively.
This management will typically involve regular monitoring of your thyroid hormone levels and blood Hypoglycemua levels, as well as implementing lifestyle changes to support overall hyperthyroidjsm.
The Paloma thyroid test kit makes it easy to monitor your thyroid hormone levels affordably from the comfort of your home. The test kit provides accurate thyroid hyperthyroidixm with convenient and painless finger-prick testing. If you want to work with a dedicated team of thyroid experts for your hypothyroidism care, consider becoming a Paloma member.
Mullur, R. Thyroid hormone regulation of metabolism. Physiological reviews, 94 2 Maratou, E. et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. European Journal of Endocrinology, 4 Vemula SL, et al.
The Impact of Hyperthyroidisk on Diabetes Mellitus and Its Complications: A Comprehensive Review. doi: PMID: ; PMCID: PMC Mary Shomon is an internationally-recognized writer, award-winning patient advocate, health coach, and activist, and the New York Times bestselling author of 15 books on health and wellness, including the Thyroid Diet Revolution and Living Well With Hypothyroidism.
On social media, Mary empowers and informs a community of more than a quarter million patients who have thyroid and hyperthyroiddism health challenges. Free guide Claim your free guide to thyroid meds Check your mailbox for your guide. Use code GETBETTER at checkout.
The Care the care. Test your thyroid See a doctor See a nutritionist Thyroid Supplements Try AIP Protocol. The Science the Science. Our Doctors Hypothyroidism Hashimoto's Our Approach Reviews. Learn Learn. Hyperthyroidiwm Thyroid Guides Community Speaker Series FAQ.
For Hypfrthyroidism Learn. For Employers For Hypoglyce,ia Plans For Health Systems For Doctor Practices. Join Our Thyroid Awareness Campaign this January! January is Thyroid Awareness Month Hgpoglycemia us this January to spotlight thyroid health.
Participate, share, and spread awareness for a chance to win exciting hyperthyroididm Hypothyroidism and Hypoglycemia: Understanding the Connection A look at the link between hypothyroidism and hypoglycemia, a condition involving low blood sugar levels.
thyroid doctors. blood tests. Last updated:. Written by:. Medically Reviewed by:. What is hypoglycemia? What are the symptoms of hypoglycemia? What is the connection between hypoglycemia and hypothyroidism? How is hypoglycemia treated?
A note from Paloma. THYROID GUIDE. Thank you! Check your mailbox for your guide. Download our Thyroid Meal Plan Find inspiration for a healthy way to support your thyroid Thank you! Hypoflycemia submission has been received! Something went wrong while submitting the form.
Dealing with Hypothyroidism? Video chat with a thyroid doctor Get answers and hyperthyroixism in minutes without leaving home - anytime. Consult with a U. board certified doctor who only treats hypothyroidism via high-quality video.
Insurance accepted. Share article: . Mary Shomon Patient Advocate Mary Shomon is an internationally-recognized writer, award-winning patient advocate, health coach, and activist, and the New York Times bestselling author of 15 books on health Hypoglucemia wellness, including the Thyroid Diet Revolution and Living Well With Hypothyroidism.
Read more. The Sirtfood Diet, Hypothyroidism, and Hashimoto's. Best Foods to Shrink Hypwrthyroidism Nodules. How Hypothyroidism Hypogpycemia Affect Your Voice.
How To Tell The Difference Between Lupus and Hashimoto's. Load More. Is Paloma Right For Me? Schedule a free, no-obligation phone consultation with one of our intake specialists to find out more.
Schedule a call. Find out if Paloma is right for you. Schedule a free call with one of our health care advisors. Schedule a Call. Thyroid Supplements Get your thyroid tested See a Doctor See a nutritionist Get your medication The thyroid mobile app.
Pricing Hypothyroidism Hashimoto's Hypothyroid specialists locations Reviews. Affiliate Program FAQ Careers Our Approach The Paloma community. Hyperthyroidixm Policy Terms of Service Informed consent HIPAA Privacy Policy © Paloma. All rights reserved. Paloma Health app the app that will change your thyroid journey Download.
: Hypoglycemia and hyperthyroidism| We Care About Your Privacy | Metabolic syndrome increases your risk for diabetes and other chronic conditions, including heart disease and stroke. OGTT, oral glucose tolerance test. In contrast, long-term treatment of the rats with T 3 10—30 d, severe hyperthyroidism increased the rates of 3- O -methylglucose transport at basal, physiological, and maximal concentrations of insulin 38 , 48 ; this suggests that severe hyperthyroidism increases the responsiveness of the glucose transport process to insulin Fig. Share This Article:. Eur J Clin Invest 24 : — The parallel stimulation of synthesis and degradation of triglycerides represents another enhanced metabolic cycle that could contribute to the increased energy expenditure of hyperthyroid subjects Continued glucose output after re-feeding contributes to glucose intolerance in hyperthyroidism. |
| What Is the Link Between Thyroid Disease and Diabetes? - Lompoc Valley Medical Center | Your documents are now available to view. Licensed Unlicensed Requires Authentication Published by De Gruyter November 1, From the journal Journal of Pediatric Endocrinology and Metabolism. Cite this Share this. Showing a limited preview of this publication:. Keywords: adrenal hyporesponsiveness ; hyperthyroidsim ; hypoglycemia. Received: Accepted: Published Online: Published in Print: Cite this article. MLA APA Harvard Chicago Vancouver. Satoh, Mari, Aso, Keiko, Ikehara, Satoshi, Komine, Yumiko and Saji, Tsutomu. Satoh, M. Journal of Pediatric Endocrinology and Metabolism , 24 , and Saji, T. Journal of Pediatric Endocrinology and Metabolism, Vol. Satoh M, Aso K, Ikehara S, Komine Y, Saji T. Journal of Pediatric Endocrinology and Metabolism. Copied to clipboard. Copy to clipboard. Download: BibTeX EndNote RIS. Share this article. Supplementary Materials. Please login or register with De Gruyter to order this product. Register Log in. Volume 24 Issue Submit manuscript. This issue. All issues. Articles in the same Issue Editorial. Intracranial cysts: large-scale information is needed. The endocrine spectrum of intracranial cysts in childhood and review of the literature. Radioiodine treatment in pediatric Graves disease and thyroid carcinoma. Images in Pediatric Endocrinology. Perineal ectopic testis: a rare cause of empty scrotum. Original Articles. Normal thyroid function in young adults who were born very preterm. Does clinical management impact height potential in children with severe acquired hypothyroidism? Neurodevelopment of preterm infants born at 28 to 36 weeks of gestational age: the role of hypothyroxinemia and long-term outcome at 4 years. This lowers blood sugar. Hyperthyroidism can contribute to insulin resistance. When you become resistant to insulin, your cells aren't able to use the glucose in your blood. As a result, blood glucose levels stay high. People with diabetes who need insulin shots may also find themselves needing higher doses. On the flip side, hypothyroidism an underactive thyroid decreases metabolism. When this happens, insulin can linger, causing blood sugar to drop hypoglycemia. For people on diabetes medications , the drop can sometimes be extreme, leading to dizziness, disorientation, and unconsciousness. Thyroid disease can affect insulin levels. Hyperthyroidism can cause blood sugar levels to rise. This can increase the risk of diabetes or make diabetes harder to control. Hypothyroidism can lead to low blood sugar. In addition to problems with glucose metabolism and insulin production, there are several other links between thyroid disease and diabetes. Type 1 diabetes is an autoimmune disease in which the immune system attacks the cells that make insulin. There are certain forms of thyroid disease, called Hashimoto's thyroiditis and Graves' disease , that are also autoimmune. Hashimoto's thyroiditis is the most common cause of hypothyroidism in the United States. Studies suggest that most people with type 1 diabetes will eventually develop Hashimoto's disease. Having low thyroid hormones could make you crave sugar and other foods. There are several reports of people with Hashimoto's thyroiditis who had cravings for carbohydrate-rich foods. Eliminating sugar-sweetened beverages and ultra-processed foods is encouraged in these cases. Graves' disease, on the other hand, causes hyperthyroidism. Thyroid hormones and insulin are both influenced by three organs that work together: the hypothalamus of the brain, the pituitary gland , and the adrenal glands. Referred to as the hypothalamic-pituitary-adrenal axis HPA axis , these organs send signals back and forth to each other and together control the body's response to stress. They do this by adjusting levels of the stress hormone cortisol. Problems with any of the organs in the HPA axis can affect how much or how little cortisol is produced. High cortisol levels can lead to hyperglycemia. Low cortisol levels can lead to hypoglycemia. Type 1 diabetes, an autoimmune form of diabetes, often occurs alongside autoimmune thyroid disease. Problems with the HPA axis, which produces the stress hormone cortisol, can lead to abnormal insulin and thyroid hormone levels. If you have been diagnosed with either thyroid disease or diabetes, achieving and maintaining your ideal weight is one of the best ways to prevent the other condition. Keeping your blood sugar or thyroid hormones under control can also help. If you have insulin resistance , in which the body doesn't respond to insulin as it should, thyroid disease can make your blood sugar harder to control. By managing insulin resistance with medications, diet, and exercise, you may be able to avoid diabetes as well as complications of thyroid disease. By managing hyperthyroidism with medications, diet, and exercise, you may also reduce your risk of type 2 diabetes. If you have diabetes or thyroid disease, maintaining an ideal weight may help you avoid getting the other condition. Properly managing your blood sugar or thyroid hormone can also help. Diabetes and thyroid disease are closely linked. If you have hyperthyroidism, your insulin levels can drop and your blood sugar can rise, increasing the risk of diabetes. If you have hypothyroidism, the opposite can occur and lead to bouts of low blood sugar. On the flip side, type 1 diabetes an autoimmune form of diabetes can increase the risk of Hashimoto's thyroiditis and Graves' disease autoimmune forms of thyroid disease. Problems with the HPA axis, a group of organs that produce the stress hormone cortisol, can also have a negative effect on insulin and thyroid hormone levels. If you have diabetes or thyroid disease, properly managing your condition and maintaining an ideal weight may reduce your risk of developing the other condition. Wang C. The relationship between type 2 diabetes mellitus and related thyroid diseases. J Diabetes Res. Eom YS, Wilson JR, Bernet VJ. Links between thyroid disorders and glucose homeostasis. Diabetes Metab J. Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. National Heart, Lung, and Blood Institute. Metabolic syndrome. Kalra S, Unnikrishnan AG, Sahay R. The hypoglycemic side of hypothyroidism. Indian J Endocrinol Metab. Fleiner HF, Bjøro T, Midthjell K, Grill V, Åsvold BO. Prevalence of thyroid dysfunction in autoimmune and type 2 diabetes: the population-based HUNT study in Norway. J Clin Endocrinol Metab. Abbott RD, Sadowski A, Alt AG. Efficacy of the autoimmune protocol diet as part of a multi-disciplinary, supported lifestyle intervention for Hashimoto's thyroiditis. Jonsdottir B, Larsson C, Carlsson A, et al. Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis. doi: Răcătăianu N, Leach N, Bondor CI, et al. |
| Hypoglycemia and Hypothyroidism: How These Two Impact Each Other | Perez G , Ungano B , Covelli A , Morrone G , Lombardi G , Scopacasa F , Rossi R Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. Madsen SN , Sonne O Increase of glucagon receptors in hyperthyroidism. Nature : — Riis AL , Jørgensen JO , Ivarsen P , Frystyk J , Weeke J , Møller N Increased protein turnover and proteolysis is an early and primary feature of short-term experimental hyperthyroidism in healthy women. J Clin Endocrinol Metab 93 : — Weinstein SP , O'Boyle E , Fisher M , Haber RS Regulation of GLUT 2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of hepatic glucose transport system. Mokuno T , Uchimura K , Hayashi R , Hayakawa N , Makino M , Nagata M , Kakizawa H , Sawai Y , Kotake M , Oda N , Nakai A , Nagasaka A , Itoh M Glucose transporter concentrations in hyper- and hypothyroid rat livers. J Endocrinol : — Dimitriadis G , Mitrou P , Lambadiari V , Boutati E , Maratou E , Koukkou E , Tzanela M , Thalassinos N , Raptis SA Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J Clin Endocrinol Metab 91 : — Iossa S , Lionetti L , Mollica MP , Crescenzo R , Barletta A , Liverini G Fat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid rats. Int J Obes Relat Metab Disord 25 : — Lam TK , Carpentier A , Lewis GF , van de Werve G , Fantus IG , Giacca A Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab : E — E Klieverik LP , Janssen SF , van Riel A , Foppen E , Bisschop PH , Serlie MJ , Boelen A , Ackermans MT , Sauerwein HP , Fliers E , Kalsbeek A Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventicular nucleus to the liver. Proc Natl Acad Sci USA : — Dimitriadis G , Parry-Billings M , Bevan S , Leighton B , Krause U , Piva T , Tegos K , Challiss RA , Wegener G , Newsholme EA The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Eur J Clin Invest 27 : — Newsholme EA , Crabtree B Substrate cycles in metabolic regulation and heat generation. Biochem Soc Symp 41 : 61 — Foss MC , Paccola GM , Saad MJ , Pimenta WP , Piccinato CE , Iazigi N Peripheral glucose metabolism in human hyperthyroidism. J Clin Endocrinol Metab 70 : — Laville M , Riou JP , Bougneres PF , Canivet B , Beylot M , Cohen R , Serusclat P , Dumontet C , Berthezene F , Mornex R Glucose metabolism in experimental hyperthyroidism: intact in vivo sensitivity to insulin with abnormal binding and increased glucose turnover. J Clin Endocrinol Metab 58 : — J Clin Endocrinol Metab 61 : — Eur J Clin Invest 18 : — Dimitriadis G , Mitrou P , Lambadiari V , Boutati E , Maratou E , Koukkou E , Panagiotakos D , Tountas N , Economopoulos T , Raptis SA Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. Dimitriadis GD , Leighton B , Vlachonikolis IG , Parry-Billings M , Challiss RA , West D , Newsholme EA Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat. Biochem J : 87 — Ho WJ , Chen ST , Tsay PK , Wang CL , Hsu TS , Kuo CT , Chen WJ Enhancement of endothelium-dependent flow-mediated vasodilation in hyperthyroidism. Clin Endocrinol Oxf 67 : — Measurements by the glucose clamp technique and continuous indirect calorimetry. Diabetes 35 : — Casla A , Rovira A , Wells JA , Dohm GL Increased glucose transporter GLUT4 protein expression in hyperthyroidism. Biochem Biophys Res Commun : — Shepherd PR , Kahn BB Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. N Engl J Med : — Castelló A , Rodríguez-Manzaneque JC , Camps M , Pérez-Castillo A , Testar X , Palacín M , Santos A , Zorzano A Perinatal hypothyroidism impairs the normal transition of GLUT 4 and GLUT 1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. J Biol Chem : — Weinstein SP , O'Boyle E , Haber RS Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle: the role of GLUT4 glucose transporter expression. Diabetes 43 : — Haber RS , Wilson CM , Weinstein SP , Pritsker A , Cushman SW Thyroid hormone increases the partitioning of glucose transporters to the plasma membrane in ARL 15 cells. Heather LC , Cole MA , Atherton HJ , Coumans WA , Evans RD , Tyler DJ , Glatz JF , Luiken JJ , Clarke K Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart. Dimitriadis G , Maratou E , Alevizaki M , Boutati E , Psara K , Papasteriades C , Raptis SA Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Horm Metab Res 37 : 15 — Khayat ZA , McCall AL , Klip A Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand. Mandarino LJ , Printz RL , Cusi KA , Kinchington P , O'Doherty RM , Osawa H , Sewell C , Consoli A , Granner DK , DeFronzo RA Regulation of hexokinase II and glycogen synthase mRNA protein, and activity in human muscle. Sugden MC , Liu YL , Holness MJ Glucose utilization by skeletal muscles in-vivo in experimental hyperthyroidism in the rat. Møller N , Nielsen S , Nyholm B , Pørksen N , Alberti KG , Weeke J Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clin Endocrinol Oxf 44 : — Dimitriadis GD , Richards SJ , Parry-Billings M , Leighton B , Newsholme EA , Challiss RA β-Adrenoreceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states. Bachman ES , Hampton TG , Dhillon H , Amende I , Wang J , Morgan JP , Hollenberg AN The metabolic and cardiovascular effects of hyperthyroidism are independent of β-adrenergic stimulation. Ladenson PW , Sherman SI , Baughman KL , Ray PE , Feldman AM Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA 89 : — Endocrinology : 6 — Carvalho-Bianco SD , Kim BW , Zhang JX , Harney JW , Ribeiro RS , Gereben B , Bianco AC , Mende U , Larsen PR Chronic cardiac-specific thyrotoxicosis increases myocardial β-adrenergic responsiveness. Mol Endocrinol 18 : — Sugden MC , Lall HS , Harris RA , Holness MJ Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation. Short KR , Nygren J , Barazzoni R , Levine J , Nair KS T3 increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and Short KR , Nygren J , Nair KS Effect of T3-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats. Valcavi R , Zini M , Portioli I Thyroid hormone and growth hormone secretion. J Endocrinol Invest 15 : — Miell JP , Taylor AM , Zini M , Maheshwari HG , Ross RJ , Valcavi R Effects of hypo- and hyperthyroidism on IGFs, growth hormone and IGF-binding proteins. J Clin Endocrinol Metab 76 : — Tosi F , Moghetti P , Castello R , Negri C , Bonora E , Muggeo M Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism. Metabolism 45 : — Rizza RA , Mandarino LJ , Gerich JE Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. J Clin Endocrinol Metab 54 : — Rizza RA , Mandarino LJ , Gerich JE Effects of growth hormone on insulin action: mechanisms of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilization. Diabetes 31 : — Ng SF , Storlien LH , Kraegen EW , Stuart MC , Chapman GE , Lazarus L Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in-vivo. Metabolism 39 : — Dimitriadis G , Parry-Billings M , Leighton B , Piva T , Dunger D , Calder P , Bond J , Newsholme E Studies on the effects of growth hormone administration in vivo on the rates of glucose transport and utilization in rat skeletal muscle. Eur J Clin Invest 24 : — Haber RS , Weinstein SP Role of glucose transporters in glucocorticoid-induced insulin resistance. Diabetes 41 : — Dimitriadis G , Leighton B , Parry-Billings M , Sasson S , Young M , Krause U , Bevan S , Piva T , Wegener G , Newsholme EA Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Taylor R , McCulloch AJ , Zeuzem S , Gray P , Clark F , Alberti KG Insulin secretion, adipocyte insulin binding and insulin sensitivity in thyrotoxicosis. Acta Endocrinol : 96 — Hagen JH Effect of insulin on the metabolism of adipose tissue from hyperthyroid rats. Matthaei S , Trost B , Hamann A , Kausch C , Benecke H , Greten H , Höppner W , Klein HH Effects of in vivo thyroid hormone status on insulin signaling and GLUT1 and GLUT4 glucose transport systems in rat adipocytes. Czech MP , Malbon CC , Kerman K , Gitomer W , Pilch PF Effect of thyroid status on insulin action in rat adipocytes and skeletal muscle. J Clin Invest 66 : — Cech JM , Amatruda JM The effect of triiodothyronine on insulin binding and action in rat adipocytes. Horm Metab Res 15 : — Arner P , Bolinder J , Wennlund A , Ostman J Influence of thyroid hormone level on insulin action in human adipose tissue. Diabetes 33 : — Pedersen O , Richelsen B , Bak J , Arnfred J , Weeke J , Schmitz O Characterization of the insulin resistance of glucose utilization in adipocytes from patients with hyper- and hypothyroidism. Acta Endocrinol : — Eur J Endocrinol : — Goto H , Sumida Y , Nakatani K , Yano Y , Shima T Effect of triiodothyronine on glucose transport in rat adipocytes. Life Sci 61 : — Fryer LG , Holness MJ , Sugden MC Selective modification of insulin action in adipose tissue by hyperthyroidism. Rich C , Bierman EL , Schwartz IL Plasma non-esterified fatty acids in hyperthyroid states. J Clin Invest 38 : — Pucci E , Chiovato L , Pinchera A Thyroid and lipid metabolism. Int J Obes Relat Metab Disord 24 Suppl 2 : — Coppack SW , Jensen MD , Miles JM The in vivo regulation of lipolysis in humans. J Lipid Res 35 : — Frayn KN Adipose tissue as a buffer for daily lipid flux. Diabetologia 45 : — Zimmermann R , Strauss JG , Haemmerle G , Schoiswohl G , Birner-Gruenberger R , Riederer M , Lass A , Neuberger G , Eisenhaber F , Hermetter A , Zechner R Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science : — Jocken JW , Langin D , Smit E , Saris WH , Valle C , Hul GB , Holm C , Arner P , Blaak EE Adipose triglyceride ATGL and hormone-sensitive lipase HSL protein expression is decreased in the obese insulin resistant state. J Clin Endocrinol Metab 92 : — Abrams JJ , Grundy SM , Ginsberg H Metabolism of plasma triglycerides in hypothyroidism and hyperthyroidism. J Lipid Res 22 : — Lam KS , Chan MK , Yeung RT High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction: effects of treatment. Nikkilä EA , Kekki M Plasma triglyceride metabolism in thyroid disease. J Clin Invest 51 : — Tulloch B , Lewis B , Fraser TR Triglyceride metabolism in thyroid disease. Lancet 1 : — Frayn KN , Shadid S , Hamlani R , Humphreys SM , Clark ML , Fielding BA , Boland O , Coppack SW Regulation of fatty acid movement in human adipose tissue in the postabsorptive-to-postprandial transition. Tan GD , Fielding BA , Currie JM , Humphreys SM , Désage M , Frayn KN , Laville M , Vidal H , Karpe F The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 48 : 83 — Lewis GF , Carpentier A , Adeli K , Giacca A Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23 : — Heimberg M , Olubadewo JO , Wilcox HG Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Endocr Rev 6 : — Miles JM , Wooldridge D , Grellner WJ , Windsor S , Isley WL , Klein S , Harris WS Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic patients. Diabetes 52 : — Jensen MD , Caruso M , Heiling V , Miles JM Insulin regulation of lipolysis in non-diabetic and IDDM subjects. Diabetes 38 : — Stumvoll M , Jacob S , Wahl HG , Hauer B , Löblein K , Grauer P , Becker R , Nielsen M , Renn W , Häring H Suppression of systemic, intramuscular and subcutaneous adipose tissue lipolysis by insulin in humans. J Clin Endocrinol Metab 85 : — Riis AL , Gravholt CH , Djurhuus CB , Nørrelund H , Jørgensen JO , Weeke J , Møller N Elevated regional lipolysis in hyperthyroidism. J Clin Endocrinol Metab 87 : — Haluzik M , Nedvidkova J , Bartak V , Dostalova I , Vlcek P , Racek P , Taus M , Svacina S , Alesci S , Pacak K Effects of hypo- and hyperthyroidism on noradrenergic activity and glycerol concentrations in human subcutaneous abdominal adipose tissue assessed with microdialysis. J Clin Endocrinol Metab 88 : — Nedvidkova J , Haluzik M , Bartak V , Dostalova I , Vlcek P , Racek P , Taus M , Behanova M , Svacina S , Alesci S , Pacak K Changes of noradrenergic activity and lipolysis in the subcutaneous abdominal adipose tissue of hypo- and hyperthyroid patients: an in vivo microdialysis study. Ann NY Acad Sci : — Cachefo A , Boucher P , Vidon C , Dusserre E , Diraison F , Beylot M Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients. J Clin Endocrinol Metab 86 : — Beylot M , Martin C , Laville M , Riou JP , Cohen R , Mornex R Lipolytic and ketogenic fluxes in human hyperthyroidism. J Clin Endocrinol Metab 73 : 42 — Hagenfeldt L , Wennlung A , Felig P , Wahren J Turnover and splanchnic metabolism of free fatty acids in hyperthyroidism patients. J Clin Invest 67 : — Gebhard RL , Stone BG , Andreini JP , Duane WC , Evans CD , Prigge W Thyroid hormone differentially augments biliary sterol secretion in the rat. The isolated perfused liver model. J Lipid Res 33 : — Sestoft L Metabolic aspects of the calorigenic effect of thyroid hormone in mammals. Clin Endocrinol Oxf 13 : — Dimitriadis G , Boutati E , Raptis SA The importance of adipose tissue in diabetes pathophysiology and treatment. Horm Metab Res 39 : — Rabe K , Lehrke M , Parhofer KG , Broedl UC Adipokines and insulin resistance. Mol Med 14 : — Hardardóttir I , Grünfeld C , Feingold KR Effects of endotoxin and cytokines on lipid metabolism. Curr Opin Lipidol 5 : — Iglesias P , Alvarez Fidalgo P , Codoceo R , Díez JJ Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol Oxf 59 : — Santini F , Marsili A , Mammoli C , Valeriano R , Scartabelli G , Pelosini C , Giannetti M , Centoni R , Vitti P , Pinchera A Serum concentrations of adiponectin and leptin in patients with thyroid dysfunctions. J Endocrinol Invest 27 : RC5 — RC7. Altinova AE , Törüner FB , Aktürk M , Bukan N , Cakir N , Ayvaz G , Arslan M Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol Oxf 65 : — Yaturu S , Prado S , Grimes SR Changes in adipocytes hormones leptin, resistin and adiponectin in thyroid dysfunction. J Cell Biochem 93 : — Saito T , Kawano T , Saito T , Ikoma A , Namai K , Tamemoto H , Kawakami M , Ishikawa SE Elevation of serum adiponectin levels in Basedow disease. Metabolism 54 : — Yu H , Yang Y , Zhang M , Lu H , Zhang J , Wang H , Cianflone K Thyroid status influence on adiponectin, acylation stimulating protein ASP and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab Lond 3 : J Endocrinol Invest 31 : — Iglesias P , Díez JJ Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 40 : 61 — Med Sci Monit 7 : — Seven R Thyroid status and leptin in Basedow-Graves and multinodular goiter patients. J Toxicol Environ Health A 63 : — Pinkney JH , Goodrick SJ , Katz J , Johnson AB , Lightman SL , Coppack SW , Mohamed-Ali V Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol Oxf 49 : — Horm Metab Res 38 : — Klover PJ , Zimmers TA , Koniaris LG , Mooney RA Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Senn JJ , Klover PJ , Nowak IA , Mooney RA Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 : — Rotter V , Nagaev I , Smith U Interleukin-6 IL-6 induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. Carey AL , Steinberg GR , Macaulay SL , Thomas WG , Holmes AG , Ramm G , Prelovsek O , Hohnen-Behrens C , Watt MJ , James DE , Kemp BE , Pedersen BK , Febbraio MA Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55 : — Al-Khalili L , Bouzakri K , Glund S , Lönnqvist F , Koistinen HA , Krook A Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol 20 : — Saudi Med J 21 : — Mitrou P , Boutati E , Lambadiari V , Tsegka A , Raptis AE , Tountas N , Economopoulos T , Raptis SA , Dimitriadis G Insulin resistance in hyperthyroidism: the role of IL6 and TNFα. Pontikides N , Krassas GE Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid 17 : — Senturk T , Kozaci LD , Kok F , Kadikoylu G , Bolaman Z Proinflammatory cytokine levels in hyperthyroidism. Clin Invest Med 26 : 58 — Celik I , Akalin S , Erba° T Serum levels of interleukin 6 and tumor necrosis factor-α in hyperthyroid patients before and after propylthiouracil treatment. Díez JJ , Hernanz A , Medina S , Bayón C , Iglesias P Serum concentrations of tumor necrosis factor-α ΤΝF-α and soluble ΤΝF-α receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function. Clin Endocrinol Oxf 57 : — Cytokine 6 : — Feingold KR , Grunfeld C Role of cytokines in inducing hyperlipidemia. Diabetes 41 Suppl 2 : 97 — Krassas GE , Pontikides N , Loustis K , Koliakos G , Constantinidis T , Panidis D Resistin levels in hyperthyroid patients before and after restoration of thyroid function: relationship with body weight and body composition. Fukuhara A , Matsuda M , Nishizawa M , Segawa K , Tanaka M , Kishimoto K , Matsuki Y , Murakami M , Ichisaka T , Murakami H , Watanabe E , Takagi T , Akiyoshi M , Ohtsubo T , Kihara S , Yamashita S , Makishima M , Funahashi T , Yamanaka S , Hiramatsu R , Matsuzawa Y , Shimomura I Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Tsiotra PC , Tsigos C , Yfanti E , Anastasiou E , Vikentiou M , Psarra K , Papasteriades C , Raptis SA Visfatin, TNFα and IL6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Haider DG , Schindler K , Schaller G , Prager G , Wolzt M , Ludvik B Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. Chu CH , Lee JK , Wang MC , Lu CC , Sun CC , Chuang MJ , Lam HC Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism. Metabolism 57 : — Ozkaya M , Sahin M , Cakal E , Yuzbasioglu F , Sezer K , Kilinc M , Imrek SS Visfatin plasma concentrations in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. J Endocrinol Invest 32 : — Hales CN , Hyams DE Plasma concentrations of glucose non-esterified fatty acid, and insulin during oral glucose tolerance tests in thyrotoxicosis. Lancet 2 : 69 — Andreani D , Menzinger G , Fallucca F , Aliberti G , Tamburrano G , Cassano C Insulin levels in thyrotoxicosis and primary myxoedema: response to intravenous glucose and glucagon. Diabetologia 6 : 1 — 7. Renauld A , Pinto JE , Sverdlik RC , Foglia VG Studies on the effects of hyperthyroidism on the insulin response to hyperglycemia in the dog. Horm Metab Res 3 : — Seino Y , Goto Y , Taminato T , Ikeda M , Imura H Plasma insulin and glucagon response to arginine in patients with thyroid dysfunction. J Clin Endocrinol Metab 38 : — Cavagnini F , Peracchi M , Raggi U , Bana R , Pontiroli AE , Malinverni A , Pinto M Impairment of growth hormone and insulin secretion in hyperthyroidism. Eur J Clin Invest 4 : 71 — Lenzen S , Joost HG , Hasselblatt A Thyroid function and insulin secretion from the perfused pancreas in the rat. Endocrinology 99 : — Ahrén B , Lundquist I , Hedner P , Valdemarsson S , Scherstén B Glucose tolerance and insulin and C-peptide responses after various insulin secretion stimuli in hyper- and hypothyroid subjects before and after treatment. Diabetes Res 2 : 95 — Roti E , Braverman LE , Robuschi G , Salvi M , Gardini E , d'Amato L , Maestri D , Montermini M , Borciani E , Pezzarossa A Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide and glucagon in hyperthyroid patients. Metabolism 35 : — Roubsanthisuk W , Watanakejorn P , Tunlakit M , Sriussadaporn S Hyperthyroidism induces glucose intolerance by lowering both insulin secretion and peripheral insulin sensitivity. J Med Assoc Thai 89 Suppl 5 : S — S Holness MJ , Greenwood GK , Smith ND , Sugden MC PPARα activation and increased dietary lipid oppose thyroid hormone signaling and rescue impaired glucose-stimulated insulin secretion in hyperthyroidism. Doar JW , Stamp TC , Wynn V , Audhya TK Effects of oral and intravenous glucose loading in thyrotoxicosis: studies of plasma glucose, free fatty acids, plasma insulin and blood pyruvate levels. Diabetes 18 : — Marecek RL , Feldman JM Effect of hyperthyroidism on insulin and glucose dynamics in rabbits. Endocrinology 92 : — Andersen OO , Friis T , Ottesen B Glucose tolerance insulin secretion in hyperthyroidism. Acta Endocrinol 84 : — Wajchenberg BL , Cesar FP , Leme CE , Souza IT , Pieroni RR , Mattar E Carbohydrate metabolism in thyrotoxicosis: studies on insulin secretion before and after remission from the hyperthyroid state. Horm Metab Res 10 : — Wahren J , Wennlund A , Nilsson LH , Felig P Influence of hyperthyroidism on splachnic exchange of glucose and gluconeogenesis precursors. Asano T , Okumura M Insulin delivery rates in response to glucose and arginine infusion in hyperthyroidism. Diabetologia 23 : — Diabetes Care 7 : — J Clin Endocrinol Metab 60 : — Jap TS , Ho LT , Won JG Insulin secretion and sensitivity in hyperthyroidism. Horm Metab Res 21 : — Al-Shoumer KA , Vasanthy BA , Al-Zaid MM Effects of treatment of hyperthyroidism on glucose homeostasis, insulin secretion, and markers of bone turnover. Endocr Pract 12 : — Intern Med 34 : — Gonzalo MA , Grant C , Moreno I , Garcia FJ , Suárez AI , Herrera-Pombo JL , Rovira A Glucose tolerance, insulin secretion, insulin sensitivity and glucose effectiveness in normal and overweight hyperthyroid women. Clin Endocrinol Oxf 45 : — Mitrakou A , Kelley D , Mokan M , Veneman T , Pangburn T , Reilly J , Gerich J Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. Malaisse WJ , Malaisse-Lagae F , McCraw EF Effects of thyroid function upon insulin secretion. Diabetes 16 : — Lenzen S Dose-response studies on the inhibitory effect of thyroid hormones on insulin secretion in the rat. Metabolism 27 : 81 — Fukuchi M , Shimabukuro M , Shimajiri Y , Oshiro Y , Higa M , Akamine H , Komiya I , Takasu N Evidence for a deficient pancreatic β-cell response in a rat model of hyperthyroidism. Life Sci 71 : — Dimitriadis G , Maratou E , Boutati E , Kollias A , Tsegka K , Alevizaki M , Peppa M , Raptis SA , Hadjidakis DJ IGF-1 increases the recruitment of GLUT4 and GLUT3 glucose transporters on cell surface in hyperthyroidism. Clin Endocrinol Oxf 44 : 59 — Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide. Sign In or Create an Account. Navbar Search Filter Endocrine Reviews This issue Endocrine Society Journals Clinical Medicine Endocrinology and Diabetes Medicine and Health Books Journals Oxford Academic Mobile Enter search term Search. Endocrine Society Journals. Advanced Search. Search Menu. Article Navigation. Close mobile search navigation Article Navigation. Volume Article Contents I Introduction. II Gastric Emptying and Intestinal Absorption. III Glucose Production. IV The Importance of Cori Cycle. V Glucose Utilization in Skeletal Muscle and Adipose Tissue. VI Lipid Metabolism in Adipose Tissue. VII The Role of Cytokines. VIII Insulin Secretion. IX Concluding Remarks. Journal Article. Insulin Action in Hyperthyroidism: A Focus on Muscle and Adipose Tissue. Panayota Mitrou , Panayota Mitrou. Oxford Academic. Sotirios A. George Dimitriadis. PDF Split View Views. Cite Cite Panayota Mitrou, Sotirios A. Select Format Select format. ris Mendeley, Papers, Zotero. enw EndNote. bibtex BibTex. txt Medlars, RefWorks Download citation. Permissions Icon Permissions. Close Navbar Search Filter Endocrine Reviews This issue Endocrine Society Journals Clinical Medicine Endocrinology and Diabetes Medicine and Health Books Journals Oxford Academic Enter search term Search. Open in new tab Download slide. Google Scholar Crossref. Search ADS. A hypothesis of synergism: the interrelatioship of T3 and insulin to disturbances in metabolic homeostasis. Google Scholar OpenURL Placeholder Text. Influence of gastric emptying rate and of insulin response on oral glucose tolerance in thyroid disease. Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man. Google Scholar PubMed. OpenURL Placeholder Text. Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying. Effect of hyperthyroidism on the transit of a caloric solid-liquid meal through the stomach, the small intestine, and the colon in man. Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Rapid and direct stimulation of hepatic gluconeogenesis by L-triiodothyronine in the isolated perfused rat liver. Glucose turnover and indices of recycling in thyrotoxicosis and primary thyroid failure. Triiodothyronine increases splachnic release and peripheral uptake of glucose in healthy human. Hepatic glucose production and splachnic glucose exchange in hyperthyroidism. Continued glucose output after re-feeding contributes to glucose intolerance in hyperthyroidism. Influence of thyroid state on the effects of glycerol on gluconeogenesis and energy metabolism in perfused rat liver. Metabolism of glucose in hyper- and hypothyroid rats in vivo: glucose turnover values and futile cycle activities obtained with 14 C and 3 H labeled glucose. Metabolism of glucose in hyper- and hypothyroid rats in vivo: minor role of endogenous insulin in thyroid-dependent changes in glucose turnover. Metabolism of glucose in hyper- and hypothyroid rats in vivo: relation of catecholamine actions to thyroid activity in controlling glucose turnover. Glucose and free fatty acid turnover in thyrotoxicosis and hypothyroidism, before and after treatment. Effect of thyroid states on the Cori cycle, glucose-alanine cycle and futile cycling of glucose metabolism in rats. The effect of thyroid hormones on gluconeogenesis and forearm metabolism in man. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo. Google Scholar Google Preview OpenURL Placeholder Text. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism. Increased protein turnover and proteolysis is an early and primary feature of short-term experimental hyperthyroidism in healthy women. Regulation of GLUT 2 glucose transporter expression in liver by thyroid hormone: evidence for hormonal regulation of hepatic glucose transport system. Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. Fat balance and serum leptin concentrations in normal, hypothyroid, and hyperthyroid rats. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Thyroid hormone modulates glucose production via a sympathetic pathway from the hypothalamic paraventicular nucleus to the liver. The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats. Glucose metabolism in experimental hyperthyroidism: intact in vivo sensitivity to insulin with abnormal binding and increased glucose turnover. Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. Effects of hyperthyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat. Enhancement of endothelium-dependent flow-mediated vasodilation in hyperthyroidism. Increased glucose transporter GLUT4 protein expression in hyperthyroidism. Glucose transporters and insulin action—implications for insulin resistance and diabetes mellitus. Perinatal hypothyroidism impairs the normal transition of GLUT 4 and GLUT 1 glucose transporters from fetal to neonatal levels in heart and brown adipose tissue. Thyroid hormone increases basal and insulin-stimulated glucose transport in skeletal muscle: the role of GLUT4 glucose transporter expression. Thyroid hormone increases the partitioning of glucose transporters to the plasma membrane in ARL 15 cells. Adenosine monophosphate-activated protein kinase activation, substrate transporter translocation, and metabolism in the contracting hyperthyroid rat heart. Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Unique mechanism of GLUT3 glucose transporter regulation by prolonged energy demand. Regulation of hexokinase II and glycogen synthase mRNA protein, and activity in human muscle. Glucose utilization by skeletal muscles in-vivo in experimental hyperthyroidism in the rat. Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. β-Adrenoreceptor-agonist and insulin actions on glucose metabolism in rat skeletal muscle in different thyroid states. The metabolic and cardiovascular effects of hyperthyroidism are independent of β-adrenergic stimulation. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Chronic cardiac-specific thyrotoxicosis increases myocardial β-adrenergic responsiveness. Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation. T3 increases mitochondrial ATP production in oxidative muscle despite increased expression of UCP2 and Effect of T3-induced hyperthyroidism on mitochondrial and cytoplasmic protein synthesis rates in oxidative and glycolytic tissues in rats. Effects of hypo- and hyperthyroidism on IGFs, growth hormone and IGF-binding proteins. Early changes in plasma glucagon and growth hormone response to oral glucose in experimental hyperthyroidism. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a post-receptor defect of insulin action. Effects of growth hormone on insulin action: mechanisms of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilization. Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in-vivo. Studies on the effects of growth hormone administration in vivo on the rates of glucose transport and utilization in rat skeletal muscle. Role of glucose transporters in glucocorticoid-induced insulin resistance. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Insulin secretion, adipocyte insulin binding and insulin sensitivity in thyrotoxicosis. Effect of insulin on the metabolism of adipose tissue from hyperthyroid rats. In some instances, you may also be given beta blockers to reduce your symptoms or have surgery to remove the thyroid. An estimated population, reports the CDC. It adds that 8. adults, remain undiagnosed with diabetes. In a study published in Endocrine Reviews , researchers evaluated the relationship between thyroid disorders and diabetes. They also learned that thyroid disorders are more common among people with type 2 diabetes than among the general population. Your body uses blood sugar also known as glucose for energy. The hormones produced by your thyroid help regulate your metabolism by converting foods into energy. This can lead to high blood sugar levels, which increase the risk of diabetes. If you already have diabetes, thyroid problems can make it more difficult for you to manage your condition. High blood sugar is also known as hyperglycemia. This condition can contribute to metabolic syndrome. Metabolic syndrome is a group of conditions that include high blood pressure, abnormal cholesterol, high blood sugar, and excess body fat around the waist. Metabolic syndrome increases your risk for diabetes and other chronic conditions, including heart disease and stroke. Insulin helps your body use glucose for energy, which can lower your blood sugar level. However, an overactive thyroid can cause your body to use up insulin more quickly than usual. This can increase your risk for type 2 diabetes. If you already have diabetes, you may find that you need higher doses of insulin to avoid spikes in blood sugar. On the other hand, if you have an underactive thyroid, your metabolism will be lower than usual. This can lead to low blood sugar levels, which is known as hypoglycemia. If you already have diabetes, hypoglycemia can cause you to experience symptoms, including dizziness, confusion, and loss of consciousness. Type 1 diabetes is an autoimmune disease. This means that if you have type 1 diabetes, your immune system will attack the cells that produce insulin. If your immune system is already compromised by an autoimmune disorder, your risk for other disorders increases. According to a study published in the Journal of Clinical Endocrinology and Metabolism , the majority of people with type 1 diabetes will eventually develop Hashimoto's thyroiditis. The HPA axis consists of the hypothalamus of the brain, the pituitary gland, and the adrenal glands. These organs work together to regulate cortisol, which is a stress hormone. If any of the organs that make up the HPA axis are affected, your body could make too much or too little cortisol. Too much cortisol can lead to high blood sugar, and too little cortisol can lead to low blood sugar. Imbalances in cortisol can upset the balance of all your other hormones, including insulin and thyroid hormone. If you have thyroid disease or diabetes, the best thing you can do to reduce your risk for the other condition is to work closely with your doctor to manage your current condition. An underactive thyroid can be treated with medication that supplies your body with extra thyroid hormone. An overactive thyroid can be treated with medications that prevent or block your thyroid hormone from making any more hormone. Radioiodine and surgery are other treatment options for an overactive thyroid. Radioiodine destroys the cells in your thyroid that make the hormone. Surgery involves removing a part or all of the thyroid. Both of these treatments result in permanent hypothyroidism, and you may be required to take thyroid replacement hormones for life to avoid other problems. Diabetes can often be effectively managed with a combination of medications, diet, and exercise. Maintaining a healthy weight is also essential to successfully managing diabetes and reducing your risk for thyroid disease. Take all your diabetes medications as directed. Check your blood sugar levels regularly, and notify your doctor right away if they are too high or too low. Work with your doctor to create a healthy diabetes meal plan. Eat healthy carbohydrates, including fruits, vegetables, whole grains, beans, and low-fat dairy products. Many of these foods are also high in fiber, which can help you control your blood sugar. Also, eat plenty of healthy fats like avocados, walnuts, and olive oil, and heart-healthy fish like tuna, salmon, and mackerel. |
Ich werde besser wohl stillschweigen
Ich denke, dass Sie nicht recht sind. Ich biete es an, zu besprechen.